TY - JOUR
T1 - Neurological manifestations of COVID-19 in adults and children
AU - ISARIC Clinical Characterisation Group
AU - Cho, Sung Min
AU - White, Nicole
AU - Premraj, Lavienraj
AU - Battaglini, Denise
AU - Fanning, Jonathon
AU - Suen, Jacky Y.
AU - Bassi, Gianluigi Li
AU - Fraser, John F.
AU - Robba, Chiara
AU - Griffee, Matthew
AU - Singh, Bhagteshwar
AU - Citarella, Barbara Wanjiru
AU - Merson, Laura
AU - Solomon, Tom
AU - Thomson, David
AU - Abbas, Ali
AU - Abdulkadir, Nurul Najmee
AU - Abe, Ryuzo
AU - Abel, Laurent
AU - Absil, Lara
AU - Acharya, Subhash
AU - Acker, Andrew
AU - Adrião, Diana
AU - Ageel, Saleh Al
AU - Ahmed, Shakeel
AU - Ainscough, Kate
AU - Aisa, Tharwat
AU - Hssain, Ali Ait
AU - Tamlihat, Younes Ait
AU - Akimoto, Takako
AU - Akmal, Ernita
AU - Alalqam, Razi
AU - Al-Dabbous, Tala
AU - Alegesan, Senthilkumar
AU - Alegre, Cynthia
AU - Alex, Beatrice
AU - Alexandre, Kevin
AU - Al-Fares, Abdulrahman
AU - Cardoso, Filipa
AU - Chan, Adrienne
AU - Oliveira, Ana Isabel de Pinho
AU - Vries, Peter de
AU - Dieperink, Wim
AU - Nguyen, Duc
AU - Postma, Douwe F.
AU - Raza, Ali
AU - Stienstra, Ymkje
AU - Talsma, Jelmer
AU - Valk, Paul van der
AU - Voort, Peter Van der
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of the Guarantors of Brain.
PY - 2023/4
Y1 - 2023/4
N2 - Different neurological manifestations of coronavirus disease 2019 (COVID-19) in adults and children and their impact have not been well characterized. We aimed to determine the prevalence of neurological manifestations and in-hospital complications among hospitalized COVID-19 patients and ascertain differences between adults and children. We conducted a prospective multicentre observational study using the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) cohort across 1507 sites worldwide from 30 January 2020 to 25 May 2021. Analyses of neurological manifestations and neurological complications considered unadjusted prevalence estimates for predefined patient subgroups, and adjusted estimates as a function of patient age and time of hospitalization using generalized linear models. Overall, 161 239 patients (158 267 adults; 2972 children) hospitalized with COVID-19 and assessed for neurological manifestations and complications were included. In adults and children, the most frequent neurological manifestations at admission were fatigue (adults: 37.4%; children: 20.4%), altered consciousness (20.9%; 6.8%), myalgia (16.9%; 7.6%), dysgeusia (7.4%; 1.9%), anosmia (6.0%; 2.2%) and seizure (1.1%; 5.2%). In adults, the most frequent in-hospital neurological complications were stroke (1.5%), seizure (1%) and CNS infection (0.2%). Each occurred more frequently in intensive care unit (ICU) than in non-ICU patients. In children, seizure was the only neurological complication to occur more frequently in ICU versus non-ICU (7.1% versus 2.3%, P < 0.001). Stroke prevalence increased with increasing age, while CNS infection and seizure steadily decreased with age. There was a dramatic decrease in stroke over time during the pandemic. Hypertension, chronic neurological disease and the use of extracorporeal membrane oxygenation were associated with increased risk of stroke. Altered consciousness was associated with CNS infection, seizure and stroke. All in-hospital neurological complications were associated with increased odds of death. The likelihood of death rose with increasing age, especially after 25 years of age. In conclusion, adults and children have different neurological manifestations and in-hospital complications associated with COVID-19. Stroke risk increased with increasing age, while CNS infection and seizure risk decreased with age.
AB - Different neurological manifestations of coronavirus disease 2019 (COVID-19) in adults and children and their impact have not been well characterized. We aimed to determine the prevalence of neurological manifestations and in-hospital complications among hospitalized COVID-19 patients and ascertain differences between adults and children. We conducted a prospective multicentre observational study using the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) cohort across 1507 sites worldwide from 30 January 2020 to 25 May 2021. Analyses of neurological manifestations and neurological complications considered unadjusted prevalence estimates for predefined patient subgroups, and adjusted estimates as a function of patient age and time of hospitalization using generalized linear models. Overall, 161 239 patients (158 267 adults; 2972 children) hospitalized with COVID-19 and assessed for neurological manifestations and complications were included. In adults and children, the most frequent neurological manifestations at admission were fatigue (adults: 37.4%; children: 20.4%), altered consciousness (20.9%; 6.8%), myalgia (16.9%; 7.6%), dysgeusia (7.4%; 1.9%), anosmia (6.0%; 2.2%) and seizure (1.1%; 5.2%). In adults, the most frequent in-hospital neurological complications were stroke (1.5%), seizure (1%) and CNS infection (0.2%). Each occurred more frequently in intensive care unit (ICU) than in non-ICU patients. In children, seizure was the only neurological complication to occur more frequently in ICU versus non-ICU (7.1% versus 2.3%, P < 0.001). Stroke prevalence increased with increasing age, while CNS infection and seizure steadily decreased with age. There was a dramatic decrease in stroke over time during the pandemic. Hypertension, chronic neurological disease and the use of extracorporeal membrane oxygenation were associated with increased risk of stroke. Altered consciousness was associated with CNS infection, seizure and stroke. All in-hospital neurological complications were associated with increased odds of death. The likelihood of death rose with increasing age, especially after 25 years of age. In conclusion, adults and children have different neurological manifestations and in-hospital complications associated with COVID-19. Stroke risk increased with increasing age, while CNS infection and seizure risk decreased with age.
KW - COVID-19
KW - encephalitis
KW - meningitis
KW - neurological complication
KW - seizure
KW - stroke
UR - https://www.scopus.com/pages/publications/85148647513
U2 - 10.1093/brain/awac332
DO - 10.1093/brain/awac332
M3 - Article
C2 - 36087305
AN - SCOPUS:85148647513
SN - 0006-8950
VL - 146
SP - 1648
EP - 1661
JO - Brain
JF - Brain
IS - 4
ER -